3.0.0
1730
2023-03-08T20:26:38Z
2023-03-08T20:26:38Z
House
HR
2021-03-10
117
[Congressional Record Volume 167, Number 45 (Wednesday, March 10, 2021)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. BILIRAKIS:H.R. 1730.Congress has the power to enact this legislation pursuantto the following:This bill is enacted pursuant to Article 1, Section 8,Clause 18 of the Constitution of the United States.[Page H1326]
- hsif00
Energy and Commerce Committee
House
Standing
  - hsif14
Health Subcommittee
    - Referred to
2021-03-10T14:58:16Z
  - Referred to
2021-03-10T14:01:40Z

- Speeding Therapy Access Today Act of 2021
117
670
S
2021-03-10
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  - Identical bill
CRS
- 2021-03-10
  - hsif14
Health Subcommittee
1
House committee actions
Referred to the Subcommittee on Health.
Committee
- 2021-03-10
Referred to the House Committee on Energy and Commerce.
IntroReferral
H11100
2
House floor actions
  - hsif00
Energy and Commerce Committee
- 2021-03-10
Introduced in House
IntroReferral
Intro-H
9
Library of Congress
- 2021-03-10
Introduced in House
IntroReferral
1000
9
Library of Congress
- B001257
Rep. Bilirakis, Gus M. [R-FL-12]
Gus
Bilirakis
R
FL
M.
12
N
- B001251
Rep. Butterfield, G. K. [D-NC-1]
G. K.
Butterfield
D
NC
1
2021-03-10
True
- S001200
Rep. Soto, Darren [D-FL-9]
Darren
Soto
D
FL
9
2021-03-16
False
- H000324
Rep. Hastings, Alcee L. [D-FL-20]
ALCEE
HASTINGS
D
FL
L.
20
2021-03-23
False
- V000133
Rep. Van Drew, Jefferson [R-NJ-2]
Jefferson
Van Drew
R
NJ
2
2021-04-05
False
- L000593
Rep. Levin, Mike [D-CA-49]
Mike
Levin
D
CA
49
2021-04-19
False
- J000302
Rep. Joyce, John [R-PA-13]
John
Joyce
R
PA
13
2021-04-26
False
- D000619
Rep. Davis, Rodney [R-IL-13]
Rodney
Davis
R
IL
13
2021-05-11
False
- T000478
Rep. Tenney, Claudia [R-NY-22]
Claudia
Tenney
R
NY
22
2021-05-11
False
- L000590
Rep. Lee, Susie [D-NV-3]
Susie
Lee
D
NV
3
2021-05-12
False
- W000826
Rep. Wild, Susan [D-PA-7]
Susan
Wild
D
PA
7
2021-05-14
False
- F000466
Rep. Fitzpatrick, Brian K. [R-PA-1]
Brian
Fitzpatrick
R
PA
K.
1
2021-05-17
False
- D000630
Rep. Delgado, Antonio [D-NY-19]
Antonio
Delgado
D
NY
19
2021-05-18
False
- L000589
Rep. Lesko, Debbie [R-AZ-8]
Debbie
Lesko
R
AZ
8
2021-06-01
False
- N000179
Rep. Napolitano, Grace F. [D-CA-32]
GRACE
NAPOLITANO
D
CA
F.
32
2021-06-01
False
- J000020
Rep. Jacobs, Chris [R-NY-27]
Chris
Jacobs
R
NY
27
2021-06-11
False
- C001053
Rep. Cole, Tom [R-OK-4]
Tom
Cole
R
OK
4
2021-06-15
False
- N000147
Del. Norton, Eleanor Holmes [D-DC-At Large]
ELEANOR
NORTON
D
DC
HOLMES
0
2021-07-22
False
- K000376
Rep. Kelly, Mike [R-PA-16]
Mike
Kelly
R
PA
16
2021-07-22
False
- R000305
Rep. Ross, Deborah K. [D-NC-2]
Deborah
Ross
D
NC
K.
2
2021-07-22
False
- K000392
Rep. Kustoff, David [R-TN-8]
David
Kustoff
R
TN
8
2021-08-03
False
- G000583
Rep. Gottheimer, Josh [D-NJ-5]
Josh
Gottheimer
D
NJ
5
2021-08-03
False
- H001068
Rep. Huffman, Jared [D-CA-2]
Jared
Huffman
D
CA
2
2021-10-15
False
- D000623
Rep. DeSaulnier, Mark [D-CA-11]
Mark
DeSaulnier
D
CA
11
2021-10-15
False
- L000562
Rep. Lynch, Stephen F. [D-MA-8]
Stephen
Lynch
D
MA
F.
8
2021-10-21
False
- P000616
Rep. Phillips, Dean [D-MN-3]
Dean
Phillips
D
MN
3
2021-12-23
False
- N000191
Rep. Neguse, Joe [D-CO-2]
Joe
Neguse
D
CO
2
2022-02-08
False
- G000582
Resident Commissioner González-Colón, Jenniffer [R-PR-At Large]
Jenniffer
Gonzalez-Colon
R
PR
0
2022-02-25
False
- Y000062
Rep. Yarmuth, John A. [D-KY-3]
John
Yarmuth
D
KY
A.
3
2022-03-09
False
- D000631
Rep. Dean, Madeleine [D-PA-4]
Madeleine
Dean
D
PA
4
2022-03-09
False
- B000490
Rep. Bishop, Sanford D., Jr. [D-GA-2]
SANFORD
BISHOP
D
GA
D.
2
2022-03-09
False
- A000378
Rep. Axne, Cynthia [D-IA-3]
Cynthia
Axne
D
IA
3
2022-03-09
False
- S001193
Rep. Swalwell, Eric [D-CA-15]
Eric
Swalwell
D
CA
15
2022-03-09
False
- S001218
Rep. Stansbury, Melanie Ann [D-NM-1]
Melanie
Stansbury
D
NM
Ann
1
2022-03-11
False
- O000171
Rep. O'Halleran, Tom [D-AZ-1]
Tom
O'Halleran
D
AZ
1
2022-03-11
False
- W000795
Rep. Wilson, Joe [R-SC-2]
Joe
Wilson
R
SC
2
2022-03-15
False
- C001121
Rep. Crow, Jason [D-CO-6]
Jason
Crow
D
CO
6
2022-03-15
False
- H001072
Rep. Hill, J. French [R-AR-2]
J.
Hill
R
AR
French
2
2022-03-18
False
- M001163
Rep. Matsui, Doris O. [D-CA-6]
Doris
Matsui
D
CA
O.
6
2022-03-18
False
- M001190
Rep. Mullin, Markwayne [R-OK-2]
Markwayne
Mullin
R
OK
2
2022-03-31
False
- B001298
Rep. Bacon, Don [R-NE-2]
Don
Bacon
R
NE
2
2022-04-21
False
Health
- Advisory bodies
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Executive agency funding and structure
- Food and Drug Administration (FDA)
- Health technology, devices, supplies
- Manufacturing
- Medical research
- Research administration and funding
Health
00
2021-03-10
Introduced in House
2021-06-24T22:47:44Z
Speeding Therapy Access Today Act of 2021
This bill requires and authorizes various actions to accelerate the development of therapies for rare diseases.
The Food and Drug Administration (FDA) shall establish the Intercenter Institute on Rare Diseases and Conditions. The institute shall (1) coordinate engagement with relevant stakeholders, (2) build the FDA's expertise in the review of medical products to treat rare diseases, (3) coordinate regulatory science initiatives related to rare diseases, (4) establish and implement a program to make recommendations to address challenges associated with developing medical products to treat rare diseases in an individual or in very small populations, (5) convene a stakeholder meeting to consider potential amendments to labels for medical products to treat rare diseases, and (6) establish and carry out a program to facilitate voluntary communication between the sponsors of such medical products and third-party payers (e.g., insurance companies).
The bill also authorizes the FDA to make grants to assist in developing practices related to the development and production of individualized therapies or therapies to treat very small populations.
The bill also establishes an advisory committee to advise the FDA on issues related to the development of therapies to treat rare diseases.

Speeding Therapy Access Today Act of 2021
- Display Title

Speeding Therapy Access Today Act of 2021
- Official Title as Introduced

To amend the Federal Food, Drug, and Cosmetic Act to accelerate development of therapies across the spectrum of rare diseases and conditions and facilitate patient access to such therapies, and for other purposes.
Introduced in House
IH
- Short Title(s) as Introduced

Speeding Therapy Access Today Act of 2021
Introduced in House
IH
- Introduced in House
2021-03-10T05:00:00Z
  - https://www.govinfo.gov/content/pkg/BILLS-117hr1730ih/xml/BILLS-117hr1730ih.xml
2021-03-10
Referred to the Subcommittee on Health.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.